Item 1A. Risk Factors
ITEM
1A. RISK FACTORS
Investing
in our Common Stock involves a high degree of risk. These risks are more fully described in the section titled “Risk Factors”
included in our prospectus filed with the SEC pursuant to Rule 424(b) under the Securities Act on August 9, 2024 (the “Prospectus”)
in addition to the information in this Quarterly Report. Any of these factors could result in a material adverse effect on our results
of operations or financial condition. A summary of these risk factors that could materially and adversely affect our business, financial
condition, operating results and prospectus include the following:
● Our limited history
makes it difficult to evaluate our business and prospects and may increase the risks associated with your investment.
● Our management has identified conditions that raise substantial doubt about
our ability to continue as a going concern.
● We are a development
stage company, and there is no guarantee that our development will result in the commercial production of lithium from brine sources.
● Pipeline of lithium
feedstock may prove to be non-viable, which could have material adverse impact on our business and operations.
● Even if we are successful
in completing all initial phases and the first commercial production at our large central refinery optimized for multiple inputs of
lithium brine inputs (the “Facility”) in Oklahoma and consistently produce battery grade lithium on a commercial scale,
we may not be successful in commencing and expanding commercial operations to support the growth of our business.
● Our products may
not qualify for use for our intended customers.
● Delays and other
obstacles may prevent the successful completion of our Facility.
● Lithium can be
highly combustible, and if we have incidents, it could adversely impact us.
● The lithium brine
industry includes well capitalized players.
● Low-cost producers
could disrupt the market and be able to provide products cheaper than the Company.
● We may be unable
to qualify for existing federal and state level grants and incentives and the grants and incentives may not be released to us as quickly
or efficiently as we anticipate or at all.
● Our success as a company
producing battery grade lithium and related products depends to a great extent on the capabilities of our partners for lithium
extraction from brine and our ability to secure capital for the implementation of brine processing plants.
● Changes in technology
or other developments could adversely affect demand for lithium compounds or result in preferences for substitute products.
● The development
of our lithium refinery is highly dependent upon the currently projected demand for and uses of lithium-based end products.
● Our future growth
and success are dependent upon consumers’ demand for electric vehicles in an automotive industry that is generally competitive,
cyclical and volatile.
41
● We may be unable
to successfully negotiate final, binding terms related to our current non-binding memoranda of understanding and letters of intent for
supply and offtake agreements, which could harm our commercial prospects.
● Our future business
prospects could be adversely affected if we are unable to enter into definitive agreements relating to contemplated joint ventures and,
if such agreements are in fact completed, there can be no assurance that the required financing for such joint ventures will be available,
that their respective projects will be completed in a timely manner, or that they will ultimately be successful.
● If we fail to adequately
protect our intellectual property or technology (including any later developed or acquired intellectual property or technology), our
competitive position could be impaired and we may lose valuable assets, generate reduced revenue and incur costly litigation to protect
our rights.
● The reduction or
elimination of government subsidies and economic incentives for alternative energy technologies, or the failure to renew such subsidies
and incentives, could reduce demand for our products, lead to a reduction in our revenues, and adversely impact our operating results
and liquidity.
● We identified material
weaknesses in our internal control over financial reporting. If we are unable to remediate these material weaknesses or if we experience
additional material weaknesses or other deficiencies in the future or otherwise fail to maintain an effective system of internal control
over financial reporting, we may not be able to accurately or timely report our financial results, which could result in loss of investor
confidence and adversely impact our stock price.
● An active trading
market for Common Stock may never develop or be sustained, which may make it difficult to sell the shares of Common Stock you receive.
● The Company’s
certificate of incorporation and bylaws, which became effective on July 8, 2024, provide for a classified board of directors, with directors
serving staggered three-year terms, which could make it more difficult for stockholders to replace a majority of the directors.
● There is no guarantee
that the warrants will ever be in the money, and they may expire worthless.
● We may redeem your
unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.
There
have been no material changes to the risk factors set forth in the Prospectus, which are incorporated herein by reference, except as
set forth below. The risk factors described in this Quarterly Report and in the Prospectus are not the only risks that we face. Additional
risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. If
any such risks materialize, it could have a material adverse effect on our business, financial condition, results of operations, and
growth prospects and cause the trading price of our Common Stock to decline. We may disclose changes to such risk factors or disclose
additional risk factors from time to time in our future filings with the SEC.
It
is not possible to predict the actual number of shares we will sell under the Purchase Agreement to B. Riley Principal Capital II, or
the actual gross proceeds resulting from those sales.
On
October 7, 2024, we entered into the Purchase Agreement with B. Riley Principal Capital
II, pursuant to which B. Riley Principal Capital II has committed to purchase up to $50,000,000 of shares of our Common Stock, subject
to certain limitations and conditions set forth in the Purchase Agreement. The shares of our Common Stock that may be issued under the
Purchase Agreement may be sold by us to B. Riley Principal Capital II at our discretion from time to time for a period of up to 36 months
(unless the Purchase Agreement is earlier terminated) beginning on the date on which the registration statement registering the shares
of Common Stock issued to B. Riley Principal Capital II for resale has been declared effective by the SEC and all other conditions to
B. Riley Principal Capital II’s obligations to purchase the Common Stock set forth in the Purchase Agreement have been initially
satisfied.
We
generally have the right to control the timing and amount of any sales of our shares of Common Stock to B. Riley Principal Capital II
under the Purchase Agreement. Sales of our Common Stock, if any, to B. Riley Principal Capital II under the Purchase Agreement will depend
upon market conditions and other factors to be determined by us. We may ultimately decide to sell to B. Riley Principal Capital II all,
some or none of the shares of our Common Stock that may be available for us to sell to B. Riley Principal Capital II pursuant to the
Purchase Agreement. Depending on market liquidity at the time, resales of those shares by B. Riley Principal Capital II may cause the
public trading price of our Common Stock to decrease.
42
Because
the per share purchase price that B. Riley Principal Capital II will pay for shares of Common Stock that we may elect to effect pursuant
to the Purchase Agreement will fluctuate based on the market prices of our Common Stock during the applicable purchase valuation period
for each purchase made pursuant to the Purchase Agreement, it is not possible for us to predict, as of the date of this Quarterly Report
and prior to any such sales, the number of shares of Common Stock that we will sell to B. Riley Principal Capital II under the Purchase
Agreement, the purchase price per share that B. Riley Principal Capital II will pay for shares purchased from us under the Purchase Agreement,
or the aggregate gross proceeds that we will receive from those purchases by B. Riley Principal Capital II under the Purchase Agreement.
Although
the Purchase Agreement provides that we may sell up to an aggregate of $50,000,000 of our Common Stock to B. Riley Principal Capital
II, only 6,500,000 shares of our Common Stock (of which 63,694 represent the commitment shares we issued to B. Riley Principal Capital
II upon our execution of the Purchase Agreement on October 7, 2024) are being registered under the Securities Act for resale by B. Riley
Principal Capital II pursuant to a Registration Statement on Form S-1. If it becomes necessary for us to issue and sell to B. Riley Principal
Capital II under the Purchase Agreement more than the 6,436,306 shares being registered in order to receive aggregate gross proceeds
equal to $50,000,000 under the Purchase Agreement, we must first (i) obtain stockholder approval to issue more than 9,569,701 shares
of Common Stock, the number of shares representing 19.99% of the shares of Common Stock outstanding immediately prior to the execution
of the Purchase Agreement, in accordance with applicable Nasdaq rules (assuming such shares to not qualify for exclusion from such share
limit because they were sold at a price exceeding the “minimum price” calculated in accordance with Nasdaq rules) and (ii)
file with the SEC one or more additional registration statements to register under the Securities Act the resale by B. Riley Principal
Capital II of any such additional shares of our Common Stock we wish to sell from time to time under the Purchase Agreement, which the
SEC must declare effective, in each case before we may elect to sell any additional shares of our Common Stock to B. Riley Principal
Capital II under the Purchase Agreement. The number of shares of Common Stock ultimately offered for resale by B. Riley Principal Capital
II is dependent upon the number of shares of Common Stock, if any, we elect to sell to B. Riley Principal Capital II under the Purchase
Agreement. Any issuance and sale by us under the Purchase Agreement of a substantial amount of shares of Common Stock in addition to
the 6,500,000 shares of Common Stock being registered for resale could cause additional substantial dilution to our stockholders. Our
inability to access a portion or the full amount available under the Purchase Agreement, in the absence of any other financing sources,
could have a material adverse effect on our business.
ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.
ITEM
3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM
4. MINE SAFETY DISCLOSURES
None.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.